Showing results (1931-1940 of 2,611) with videos related to

Sort By:
Pageof 262
Arthritis & Rheumatology (Hoboken, N.J.)|December 28, 2021
Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune DiseasesSamuel Bitoun, Julien Henry, Delphine Desjardins, et al.
BMC Cancer|July 26, 2011
Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trialNicolas Briez, Guillaume Piessen, Franck Bonnetain, et al.
Blood|December 3, 2005
Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liverAmit C Nathwani, John T Gray, Catherine Y C Ng, et al.
BMJ (Clinical Research Ed.)|October 31, 2009
Immobilisation versus immediate mobilisation after intrauterine insemination: randomised controlled trialInge M Custers, Paul A Flierman, Pettie Maas, et al.
Rheumatology (Oxford, England)|September 29, 2017
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATEJacques Morel, Arnaud Constantin, Gabriel Baron, et al.
Archives of Virology|December 5, 2008
Newcastle disease virus in West Africa: new virulent strains identified in non-commercial farmsChantal J Snoeck, Mariette F Ducatez, Ademola A Owoade, et al.
Arthritis and Rheumatism|July 1, 2009
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registryF Tubach, D Salmon, P Ravaud, et al.
Pathogens (Basel, Switzerland)|May 20, 2020
Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suisMariela Segura, Virginia Aragon, Susan L Brockmeier, et al.
Virus Evolution|December 19, 2022
Evolutionary and temporal dynamics of emerging influenza D virus in Europe (2009-22)Maria Gaudino, Chiara Chiapponi, Ana Moreno, et al.
Oncoimmunology|May 7, 2026
Sex-based considerations in the choice for a TLR9 or TLR7/8 agonist to arm the sentinel lymph node in early-stage melanomaJessica C L Notohardjo, Elisa C Toffoli, Tara Muijlwijk, et al.
Pageof 262